4-15625408-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012161.4(FBXL5):c.1694A>C(p.Glu565Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000028 in 1,461,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012161.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251132Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135746
GnomAD4 exome AF: 0.0000280 AC: 41AN: 1461844Hom.: 0 Cov.: 32 AF XY: 0.0000440 AC XY: 32AN XY: 727212
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1694A>C (p.E565A) alteration is located in exon 9 (coding exon 9) of the FBXL5 gene. This alteration results from a A to C substitution at nucleotide position 1694, causing the glutamic acid (E) at amino acid position 565 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at